I'm investing in BioMedican because it's a company positioned to greatly disrupt the cannabis industry. Unlike the common cannabinoids (CBD and THC), extracting rare cannabinoids from the plants is very expensive, unpredictable, wasteful, affected by many external factors, and hard to quality control. BioMedican has developed a unique process of producing rare cannabinoids using biosynthesis. It's a strong and protected IP based on years of scientific research. The process is inexpensive, scalable, very predictable, and produces the highest quality natural non-GMO compounds. BioMedican is founded by a group of amazing scientists with decades of biotech research and production experience. The company is very focused on turning the research into a real business, with dozens of customers interested in the BioMedican's production process. The next phase for the company is to create a steady supply of product samples and get enough customer interest to scale up the production. This is the ideal time to invest in BioMedican before the company is significantly larger. As an investor, I cherish opportunities like this - a star team with a unique product and great IP on the verge of a major leap into a great business success.